Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy

Blood

Volumn 96, Issue 8, 2000, Pages 2730-2734

  Matthews, Gail V ^a   Bower, Mark ^a   Mandalia, Sundhiya ^a   Powles, Tom ^a   Nelson, Mark R ^a   Gazzard, Brian G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL SURVIVAL; FOLLOW UP; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; LYMPHOMA; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0034667530     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.8.2730     Document Type: Article

References (18)

1. Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome
2. Spectrum of AIDS-associated malignant disorders
3. AIDS-associated non-Hodgkin's lymphoma
4. Surveillance for AIDS-defining opportunistic illnesses 1992-7 CDC Surveillance Summaries
5. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms
6. Disease progression and survival following specific AIDS-defining conditions; a retrospective cohort study of 2048 HIV-infected persons in London, AIDS
7. Declining morbidity and mortality among patients with advanced immunodeficiency virus Infection
8. Changing patterns of mortality across Europe in patients infected with HIV-1: EuroSIDA Study Group
9. Risk of HIV-related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
10. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants
11. Combination antiretroviral therapy and incidence of AIDS-related malignancies
12. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among HIV-1 infected individuals
13. Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma
14. Relations among CD4 lymphocyte count nadir, antiretroviral therapy and HIV-1 disease progression: Results from the EuroSIDA study
15. AIDS-associated non-Hodgkin's lymphoma in San Francisco
16. Human immunodeficiency virus-related lymphoma: Prognostic factors predictive of survival
17. The International Non-Hodgkin's Lymphoma Prognostic Factors Project A predictive model for aggressive non-Hodgkin's lymphoma
18. Prognostic factors in the treatment of human immunodeficiency virus-associated lymphoma; analysis of AIDS Clinical Trials Group protocol 142-low-dose versus standard dose m-BACOD plus granulocyte-macrophage colony-stimulating factor: National Institute of Allergy and Infectious Diseases